nalmefene hydrochloride

nalmefene hydrochloride (REVEX) is an FDA-listed pharmaceutical active ingredient. Associated with Indivior Europe Limited. Route of administration: intramuscular, subcutaneous. Current US regulatory status: approved.

REVEX is a marketed brand name for nalmefene hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

nalmefene hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.